Literature DB >> 21549870

Treatment strategies for sarcopenia and frailty.

Yves Rolland1, Charlotte Dupuy, Gabor Abellan van Kan, Sophie Gillette, Bruno Vellas.   

Abstract

Sarcopenia is the key feature of frailty in older people and a major determinant of adverse health outcomes such as functional limitations and disability. Resistance training and adequate protein and energy intake are the key strategies for the management of sarcopenia. Management of weight loss and resistance training are the most relevant protective countermeasures to slow down the decline of muscle mass and muscle strength. The quality of amino acids in the diet is an important factor for stimulating protein synthesis. Vitamin D deficiency should be treated, and new pharmacologic approaches for sarcopenia are currently assessed.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21549870     DOI: 10.1016/j.mcna.2011.02.008

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  23 in total

1.  Chronic hyponatremia exacerbates multiple manifestations of senescence in male rats.

Authors:  Julia Barsony; Michaele B Manigrasso; Qin Xu; Helen Tam; Joseph G Verbalis
Journal:  Age (Dordr)       Date:  2012-01-05

Review 2.  Genetic aspects of skeletal muscle strength and mass with relevance to sarcopenia.

Authors:  Stephen M Roth
Journal:  Bonekey Rep       Date:  2012-04-04

3.  Exercise and Cancer Treatment Symptoms in 408 Newly Diagnosed Older Cancer Patients.

Authors:  Lisa K Sprod; Supriya G Mohile; Wendy Demark-Wahnefried; Michelle C Janelsins; Luke J Peppone; Gary R Morrow; Raymond Lord; Howard Gross; Karen M Mustian
Journal:  J Geriatr Oncol       Date:  2012-01-27       Impact factor: 3.599

4.  Current nutritional recommendations and novel dietary strategies to manage sarcopenia.

Authors:  Riccardo Calvani; Alfredo Miccheli; Francesco Landi; Maurizio Bossola; Matteo Cesari; Christiaan Leeuwenburgh; Cornel C Sieber; Roberto Bernabei; Emanuele Marzetti
Journal:  J Frailty Aging       Date:  2013

5.  1,25(OH)(2)vitamin D(3) enhances myogenic differentiation by modulating the expression of key angiogenic growth factors and angiogenic inhibitors in C(2)C(12) skeletal muscle cells.

Authors:  Leah A Garcia; Monica G Ferrini; Keith C Norris; Jorge N Artaza
Journal:  J Steroid Biochem Mol Biol       Date:  2012-09-12       Impact factor: 4.292

6.  Frailty Phenotype and Cause-Specific Mortality in the United States.

Authors:  Matthew C Lohman; Amanda J Sonnega; Nicholas V Resciniti; Amanda N Leggett
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-09-25       Impact factor: 6.053

7.  Losartan improves measures of activity, inflammation, and oxidative stress in older mice.

Authors:  Chung-Hao Lin; Huanle Yang; Qian-Li Xue; Yi-Fang Chuang; Cindy N Roy; Peter Abadir; Jeremy D Walston
Journal:  Exp Gerontol       Date:  2014-07-28       Impact factor: 4.032

8.  Frailty and depression in older adults: a high-risk clinical population.

Authors:  Patrick J Brown; Steven P Roose; Robert Fieo; Xinhua Liu; Taina Rantanen; Joel R Sneed; Bret R Rutherford; D P Devanand; Kirsten Avlund
Journal:  Am J Geriatr Psychiatry       Date:  2013-08-20       Impact factor: 4.105

9.  Subproteomic analysis of basic proteins in aged skeletal muscle following offgel pre-fractionation.

Authors:  Joan Gannon; Kay Ohlendieck
Journal:  Mol Med Rep       Date:  2012-01-17       Impact factor: 2.952

10.  Proteomic Profiling of Fast-To-Slow Muscle Transitions during Aging.

Authors:  Kay Ohlendieck
Journal:  Front Physiol       Date:  2011-12-26       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.